Stockscreener 앱 받기
0.8018
5.66%
-0.0481
시간 외 거래:
.80
-0.0018
-0.22%
전일 마감가:
$0.8499
열려 있는:
$0.85
하루 거래량:
1.05M
Relative Volume:
1.62
시가총액:
$41.56M
수익:
-
순이익/손실:
$-81.22M
주가수익비율:
-0.2709
EPS:
-2.96
순현금흐름:
$-74.41M
1주 성능:
-2.22%
1개월 성능:
-1.98%
6개월 성능:
+6.88%
1년 성능:
-44.32%
1일 변동 폭
$0.7927
$0.8583
1주일 범위
$0.7714
$0.8989
52주 변동 폭
$0.615
$1.70
Xilio Therapeutics Inc Stock (XLO) Company Profile
명칭
Xilio Therapeutics Inc
전화
617-833-1027
주소
828 WINTER STREET, WALTHAM
XLO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XLO
Xilio Therapeutics Inc
|
0.8018 | 44.05M | 0 | -81.22M | -74.41M | -2.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Xilio Therapeutics Inc Stock (XLO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-06 | 개시 | Leerink Partners | Outperform |
| 2022-12-21 | 개시 | Chardan Capital Markets | Buy |
| 2022-01-10 | 개시 | H.C. Wainwright | Buy |
| 2021-11-16 | 개시 | Cowen | Outperform |
| 2021-11-16 | 개시 | Guggenheim | Buy |
| 2021-11-16 | 개시 | Morgan Stanley | Overweight |
| 2021-11-16 | 개시 | Raymond James | Outperform |
모두보기
Xilio Therapeutics Inc 주식(XLO)의 최신 뉴스
Is Xilio Therapeutics Inc. stock safe for conservative investorsQuarterly Growth Report & Consistent Profit Trading Strategies - newser.com
Building trade automation scripts for Xilio Therapeutics Inc.Trade Exit Report & Growth Focused Entry Reports - newser.com
Is it too late to sell Xilio Therapeutics Inc.Weekly Risk Report & AI Forecasted Entry and Exit Points - newser.com
Published on: 2025-11-04 03:36:00 - newser.com
Is it time to cut losses on Xilio Therapeutics Inc.2025 Risk Factors & Reliable Momentum Entry Alerts - newser.com
Best data tools to analyze Xilio Therapeutics Inc. stockCPI Data & Weekly Breakout Stock Alerts - newser.com
What the charts say about Xilio Therapeutics Inc. today2025 Volume Leaders & Intraday High Probability Setup Alerts - newser.com
Published on: 2025-11-04 01:21:34 - newser.com
How geopolitical tensions affect Xilio Therapeutics Inc. stock2025 Geopolitical Influence & Daily Chart Pattern Signals - newser.com
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Xilio Therapeutics (Nasdaq: XLO) grants inducement option at $0.7967 with 10-year term - Stock Titan
What makes Xilio Therapeutics Inc. stock attractive to growth funds2025 Market Outlook & Intraday High Probability Setup Alerts - newser.com
How Xilio Therapeutics Inc. stock performs in high volatility marketsJuly 2025 Setups & Free Accurate Trade Setup Notifications - newser.com
Why Xilio Therapeutics Inc. stock is in analyst buy zone2025 Growth vs Value & Free Community Supported Trade Ideas - newser.com
How Xilio Therapeutics Inc. stock compares to market leaders2025 Growth vs Value & Fast Exit and Entry Strategy Plans - newser.com
Xilio Therapeutics Inc expected to post a loss of 3 cents a shareEarnings Preview - TradingView
Tick level data insight on Xilio Therapeutics Inc. volatilityEarnings Miss & Community Verified Trade Signals - newser.com
Using data models to predict Xilio Therapeutics Inc. stock movementJuly 2025 Movers & Reliable Entry Point Alerts - newser.com
What Fibonacci levels say about Xilio Therapeutics Inc. reboundMarket Growth Report & Weekly Top Gainers Trade List - newser.com
Why analysts remain bullish on Xilio Therapeutics Inc. stockJuly 2025 Momentum & AI Enhanced Execution Alerts - newser.com
Tools to assess Xilio Therapeutics Inc.’s risk profileJuly 2025 Trends & Risk Managed Investment Signals - newser.com
Can Xilio Therapeutics Inc. stock deliver sustainable ROEPortfolio Gains Report & Stock Timing and Entry Methods - newser.com
Will Xilio Therapeutics Inc. stock remain a Wall Street favoriteJuly 2025 Retail & Accurate Trade Setup Notifications - newser.com
Is Xilio Therapeutics Inc. stock a buy before product launchesJuly 2025 Reactions & Verified Stock Trade Ideas - newser.com
Is Xilio Therapeutics Inc a good long term investmentLong-Term Growth Stocks & Small Entry Cost Investments - earlytimes.in
Why Xilio Therapeutics Inc. stock remains on watchlists2025 Trading Volume Trends & Expert Curated Trade Setup Alerts - newser.com
What machine learning models say about Xilio Therapeutics Inc.July 2025 Update & Safe Entry Zone Identification - newser.com
Volume spikes in Xilio Therapeutics Inc. stock – what they meanPortfolio Gains Summary & Fast Gain Swing Trade Alerts - newser.com
Xilio to present vilastobart phase 2 data at SITC annual meeting - Investing.com Australia
Volatility clustering patterns for Xilio Therapeutics Inc.July 2025 Catalysts & Smart Investment Allocation Insights - newser.com
Xilio Therapeutics Inc (XLO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):